VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues

Leukemia and Lymphoma

Volumn 48, Issue 10, 2007, Pages 2014-2021

  Bardelli, Monia ^a   Leucci, Eleonora ^a   Schürfeld, Karin ^a   Bellan, Cristiana ^a   Passiatore, Giovanni ^a   Rocchigiani, Marina ^a   Bartolommei, Sabrina ^a   Orlandini, Maurizio ^a   Zagursky, Jennifer ^a   Lazzi, Stefano ^a   De Falco, Giulia ^a   Tosi, Piero ^a   Oliviero, Salvatore ^a   Leoncini, Lorenzo ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Angiogenesis; Leukemia; Lymphoma; VEGF D; VEGFR 3

Indexed keywords

VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ACUTE LEUKEMIA; ARTICLE; B LYMPHOBLAST; B LYMPHOCYTE; BONE MARROW BIOPSY; CANCER RISK; CELL ACTIVATION; CONTROLLED STUDY; HEMATOPOIETIC SYSTEM TUMOR; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHATIC SYSTEM TUMOR; LYMPHOID CELL; MYELOID PROGENITOR CELL; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RISK FACTOR; T LYMPHOBLAST; TUMOR VASCULARIZATION;

ANTIBODIES, MONOCLONAL; BIOPSY; BONE MARROW CELLS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, LEUKEMIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIETIC STEM CELLS; HL-60 CELLS; HUMANS; K562 CELLS; LYMPH NODES; LYMPHOCYTES; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 35148856262     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701540975     Document Type: Article

References (35)

1. Carmeliet, P. (2003) Angiogenesis in health and disease. Nat Med, 9, pp. 653-660.
2. Ferrara, N., Gerber, H. P. and LeCouter, J. (2003) The biology of VEGF and its receptors. Nat Med, 9, pp. 669-676.
3. Kubo, H., Fujiwara, T., Jussila, L., Hashi, H., Ogawa, M. and Shimizu, K. (2000) Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood, 96, pp. 546-553.
4. Witmer, A. N., van Blijswijk, B. C., Dai, J., Hofman, P., Partanen, T. A. and Vrensen, G. F. (2001) VEGFR-3 in adult angiogenesis. J Pathol, 195, pp. 490-497.
5. Valtola, R., Salven, P., Heikkila, P., Taipale, J., Joensuu, H. and Rehn, M. (1999) VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol, 154, pp. 1381-1390.
6. Bras, B Le, Barallobre, M. J., Homman-Ludiye, J., Wyns, S. and Tammela, T. (2006) VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat Neurosci, 9, pp. 340-348.
7. Garces, C. A., Kurenova, E. V., Golubovskaya, V. M. and Cance, W. G. (2006) Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. Cancer Res, 66, pp. 1446-1454.
8. Orlandini, M., Spreafico, A., Bardelli, M., Rocchigiani, M., Salameh, A. and Nucciotti, S. (2006) Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation. J Biol Chem, 281, pp. 17961-17967.
9. Scavelli, C., Vacca, A., Pietro, G Di, Domacco, F. and Ribatti, D. (2004) Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia, 18, pp. 1054-1058.
10. Hussong, J. W., Perkins, S. L., Huff, V., McDonald, J. M., Pysher, T. J. and Beckwith, J. B. (2000) Familial Wilms' tumor with neural elements: characterization by histology, immunohistochemistry, and genetic analysis. Pediatr Dev Pathol, 3, pp. 561-567.
11. Perez-Atayde, A. R., Sallan, S. E., Tedrow, U., Connors, S., Allred, E. and Folkman, J. (1997) Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol, 150, pp. 815-821.
12. Dominici, M., Campioni, D., Lanza, F., Luppi, M., Barozzi, P. and Pauli, S. (2001) Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colonies growth (CFU-En) and clinical-biological features. Leukemia, 15, pp. 171-176.
13. Moehler, T. M., Ho, A. D., Goldschmidt, H. and Barlogie, B. (2003) Angiogenesis in hematologic malignancies. Crit Rev Oncol Hematol, 45, pp. 227-244.
14. Koster, A. and Raemaekers, J. M. (2005) Angiogenesis in malignant lymphomas. Curr Opin Oncol, 17, pp. 611-616.
15. Fiedler, W., Graeven, U., Ergun, S., Verago, S., Kilic, N. and Stockschlader, M. (1997) Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood, 89, pp. 1870-1875.
16. Vacca, A., Ribatti, D., Roncali, L. and Dammacco, F. (1995) Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leuk Lymphoma, 20, pp. 27-38.
17. Tzankov, A., Heiss, S., Ebner, S., Sterlocci, W., Schaefer, G. and Augustin, F. (2007) Angiogenesis in nodal B-cell lymphomas: A high throughput study. J Clin Pathol, 60, pp. 476-482.
18. Aguayo, A., Kantarjian, H., Manshouri, T., Gidel, C., Estey, E. and Thomas, D. (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood, 96, pp. 2240-2245.
19. Ridell, B. and Norrby, K. (2001) Intratumoral microvascular density in malignant lymphomas of B-cell origin. Apmis, 109, pp. 66-72.
20. Lundberg, L. G., Lerner, R., Sundelin, P., Rogers, R., Folkman, J. and Palmblad, J. (2000) Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol, 157, pp. 15-19.
21. Vacca, A., Ribatti, D., Roncali, L., Ranieri, G., Serio, G. and Silvestris, F. (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol, 87, pp. 503-508.
22. Dias, S., Choy, M., Alitalo, K. and Rafii, S. (2002) Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood, 99, pp. 2179-2184.
23. Kay, N. E. (2004) The angiogenic status of B-CLL B cells: Role of the VEGF receptors. Leuk Res, 28, pp. 221-222.
24. Krauth, M. T., Simonitsch, I., Aichberger, K. J., Mayerhofer, M., Sperr, W. R. and Sillaber, C. (2004) Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease. Am J Clin Pathol, 121, pp. 473-481.
25. Bairey, O., Boycov, O., Kaganovsky, E., Zimra, Y., Shaklai, M. and Rabizadeh, E. (2004) All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells. Leuk Res, 28, pp. 243-248.
26. Chen, H., Treweeke, A. T., West, D. C., Till, K. J., Cawley, J. C. and Zuzel, M. (2000) In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells. Blood, 96, pp. 3181-3187.
27. Vacca, A., Ria, R., Ribatti, D., Semeraro, F., Djonov, V. and Raimondo, F Di (2003) A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenensiis and growth in Multiple Mieloma. Haemathologica, 88, pp. 176-185.
28. Angeli, V., Ginhoux, F., Llodra, J., Quemeneur, L., Frenette, P. S. and Skobe, M. (2006) B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity, 24, pp. 203-215.
29. Fielder, W., Graeven, U., Ergun, S., Verago, S., Kilic, N. and Stockschlader, M. (1997) Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia, 11, pp. 1234-1237.
30. Salameh, A., Galvagni, F., Bardelli, M., Bussolino, F. and Oliviero, S. (2005) Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways. Blood, 106, pp. 3423-3431.
31. Orlandini, M., Semboloni, S. and Oliviero, S. (2003) Beta-catenin inversely regulates vascular endothelial growth factor-D mRNA stability. J Biol Chem, 278, pp. 44650-44656.
32. (2001) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon
33. Lazzi, S., Bellan, C., Tiacci, E., Palummo, N. and Oggioni, M. (2006) IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. J Pathol, 209:1, pp. 56-66.
34. Kvasnicka, H. M. and Thiele, J. (2004) Bone marrow angiogenesis: Methods of quantification and changes evolving in chronic myeloproliferative disorders. Histol Histopathol, 19, pp. 1245-1260.
35. Hiramatsu, A., Miwa, H., Shikomi, M., Ikai, T., Tajima, E. and Yamamoto, H. (2006) Disease-specific expression of VEGF and its receptors in AML cells: Possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML. Leuk Lymhpoma, 47, pp. 89-95.